Apellis Pharmaceuticals
APLS
#3059
Rank
NZ$9.00 B
Marketcap
NZ$70.31
Share price
0.00%
Change (1 day)
125.50%
Change (1 year)

Market capitalization of Apellis Pharmaceuticals (APLS)

Market cap: NZ$9.00 Billion

As of June 2026 Apellis Pharmaceuticals has a market cap of NZ$9.00 Billion. This makes Apellis Pharmaceuticals the world's 3059th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Apellis Pharmaceuticals from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$9.00 B65.01%
2025NZ$5.45 B-24.32%
2024NZ$7.20 B-35.74%
2023NZ$11.21 B24.55%
2022NZ$9.00 B33.64%
2021NZ$6.73 B12.24%
2020NZ$6.00 B106.54%
2019NZ$2.90 B162.68%
2018NZ$1.10 B-28.04%
2017NZ$1.53 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.46 B-83.70%๐Ÿ‡บ๐Ÿ‡ธ USA